Article info
PDFRheumatoid arthritis
Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells
- Correspondence to Dr Shiva Shahrara, Department of Medicine, University of Illinois Chicago, Chicago, Illinois, USA; shahrara{at}uic.edu
Citation
Syntenin-1-mediated arthritogenicity is advanced by reprogramming RA metabolic macrophages and Th1 cells
Publication history
- Received August 29, 2022
- Accepted December 14, 2022
- First published January 2, 2023.
Online issue publication
March 10, 2023
Article Versions
- Previous version (2 January 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.